RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Anorexia Nervosa
  Child Psychiatry
  Forensic Psychiatry
  Mood Disorders
  Peri-Natal Psychiatry
  Personality Disorders
   Bipolar Disorder
  Sleep Disorders
  Substance Abuse
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Schizophrenia Channel

subscribe to Schizophrenia newsletter
Latest Research : Psychiatry : Psychoses : Schizophrenia

   EMAIL   |   PRINT
Oct-6 protein not a biological marker for schizophrenia

Oct 24, 2005 - 2:04:00 PM
Contrary to their previous results, Ubhi and Price found no difference in Oct-6 protein or mRNA expression between patients and controls.

[RxPG] The protein Oct-6 is not a biological marker for schizophrenia. The results of a study published today in the open access journal BMC Psychiatry contradict previous findings and show that Oct-6, a protein involved in neurodevelopment, is normally expressed in the adult brain and cannot be used to identify patients with schizophrenia.

Oct-6 was shown to be expressed in the brain of patients diagnosed with schizophrenia, but not in the brain of healthy individuals, in a study led by Jack Price and published in the July 2002 issue of The American Journal of Psychiatry. Kirenjeet Ubhi and Jack Price, from Kings College London, UK have now replicated Price's original study and extended it. Their findings contradict Price's earlier study.

Events affecting brain development are thought to underlie the occurrence of schizophrenia in later life. Oct-6 plays a crucial role in neurodevelopment, and a genetic variation within the Oct-6 gene has been linked to a subset of patients with schizophrenia and bipolar disorder; therefore, Oct-6 seemed like a good candidate for a biological marker for these disorders.

Ubhi and Price extended Price's original study to include patients with bipolar disorder and major depression – it has been suggested that schizophrenia shares a common pathology with these disorders. They analysed post-mortem brain samples from 3 groups of 15 patients. The first group had been diagnosed with schizophrenia, the second group with bipolar disorder and the third group with major depressive disorder. They used 15 brain samples of matched healthy individuals as controls. Oct-6 mRNA and protein expression were determined by in-situ hybridization and immunostaining respectively.

Contrary to their previous results, Ubhi and Price found no difference in Oct-6 protein or mRNA expression between patients and controls.

Publication: Expression of POU-Domain Transcription Factor, Oct-6, in Schizophrenia, Bipolar Disorder and Major Depression; Kiren Ubhi and Jack Price; BMC Psychiatry 2005, 5:38 (24 October 2005)
On the web: www.biomedcentral.com 

Advertise in this space for $10 per month. Contact us today.

Related Schizophrenia News
Nicotine may be a treatment for some symptoms of schizophrenia
People With Schizophrenia Face Increased Risk Of Diabetes - Research
Brain recruiting pattern incorrect in Schizophrenic patients
Schizophrenia Risk Gene DISC1 Plays a Broader Role in the Development of Nervous System
Chemical maps hint at drug's effects on schizophrenia
Study challenges idea that schizophrenia is distinct in developing and developed regions
New details in schizophrenia treatment trial emerge
Abnormalities in eye movements and attention can predict risk of Schizophrenia
Possible genetic link to schizophrenia identified
Brain scan may help doctors predict schizophrenia

Subscribe to Schizophrenia Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)